References in this report (the "Quarterly Report") to "we," "us" or the
"Company" refer to CleanTech Acquisition Corp. References to our "management" or
our "management team" refer to our officers and directors, references to the
"Sponsor" refer to CleanTech Sponsor, and references to the "Co-Sponsor" refer
to CleanTech Investments. The following discussion and analysis of the Company's
financial condition and results of operations should be read in conjunction with
the unaudited condensed financial statements and the notes thereto contained
elsewhere in this Quarterly Report. Certain information contained in the
discussion and analysis set forth below includes forward-looking statements that
involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes "forward-looking statements" that are not
historical facts and involve risks and uncertainties that could cause actual
results to differ materially from those expected and projected. All statements,
other than statements of historical fact included in this Quarterly Report
including, without limitation, statements in this "Management's Discussion and
Analysis of Financial Condition and Results of Operations" regarding the
Company's financial position, business strategy and the plans and objectives of
management for future operations, are forward-looking statements. Words such as
"expect," "believe," "anticipate," "intend," "estimate," "seek" and variations
and similar words and expressions are intended to identify such forward-looking
statements. Such forward-looking statements relate to future events or future
performance, but reflect management's current beliefs, based on information
currently available. A number of factors could cause actual events, performance
or results to differ materially from the events, performance and results
discussed in the forward-looking statements. For information identifying
important factors that could cause actual results to differ materially from
those anticipated in the forward-looking statements, please refer to the Risk
Factors section of the Company's final prospectus for its Initial Public
Offering (as defined below) filed with the U.S. Securities and Exchange
Commission (the "SEC"). The Company's securities filings can be accessed on the
EDGAR section of the SEC's website at www.sec.gov. Except as expressly required
by applicable securities law, the Company disclaims any intention or obligation
to update or revise any forward-looking statements whether as a result of new
information, future events or otherwise.
Overview
We are a blank check company incorporated on June 18, 2020 as a Delaware
corporation and formed for the purpose of effectuating a merger, capital stock
exchange, asset acquisition, stock purchase, reorganization or similar business
combination with one or more businesses, which we refer to throughout this
Quarterly Report as our "initial business combination". We intend to effectuate
our initial business combination using cash from the proceeds of our initial
public offering (the "Initial Public Offering") and the private placement of the
Private Placement Warrants (as defined below), the proceeds of the sale of our
shares in connection with our initial business combination (pursuant to forward
purchase agreements or backstop agreements we may enter into following the
consummation of the Initial Public Offering or otherwise), shares issued to the
owners of the target, debt issued to bank or other lenders or the owners of the
target, or a combination of the foregoing.
Results of Operations
We have neither engaged in any operations nor generated any operating revenues
to date. Our only activities for the nine months ended September 30, 2021 were
organizational activities, those necessary to prepare for the Initial Public
Offering, described below, and, after the Initial Public Offering, identifying a
target company for a business combination. We do not expect to generate any
operating revenues until after the completion of our initial business
combination. We will generate non-operating income in the form of interest
income on cash and cash equivalents held after the Initial Public Offering. We
incur expenses as a result of being a public company (for legal, financial
reporting, accounting and auditing compliance), as well as for due diligence
expenses.
For the three months ended September 30, 2021, we had net loss of $4,438,654,
which resulted from by the change in fair value of warrant liabilities of
$3,619,500, operating and formation costs of $416,830, franchise tax expense of
$24,034, and transaction costs of $155,037, and a change in fair value of
over-allotment option liability of $225,000 which was partially offset by a net
gain on investments held in Trust Account in the amount of $1,747.
21
For the nine months ended September 30, 2021, we had net loss of $4,438,654,
which resulted from the change in fair value of warrant liabilities of
$3,619,500, transaction costs of $155,037 associated with the Initial Public
Offering, a change in fair value of over-allotment option liability of $225,000,
operating and formation costs of $416,830, and franchise tax expense of $24,034,
which was partially offset by a net gain on investments held in Trust Account in
the amount of $1,747.
For the period from June 18, 2020 (inception) through September 30, 2020, we had
a net loss of $1,000, which resulted entirely from formation costs.
Liquidity and Capital Resources
As of September 30, 2021 and December 31, 2020, the Company had $789,012 and
$25,000 in cash held outside of the Trust Account, respectively, and a working
capital surplus of $1,116,854 and $24,000, respectively.
The Company's liquidity needs prior to the consummation of the Initial Public
Offering were satisfied through the proceeds of $25,000 from the sale of the
Founder Shares, and a loan of up to $250,000 under an unsecured and non-interest
bearing promissory note. Subsequent to the consummation of the Initial Public
Offering, the Company's liquidity will be satisfied through the net proceeds
from the private placement held outside of the Trust Account.
In addition, in order to finance transaction costs in connection with a Business
Combination, our Sponsor or an affiliate of the Sponsor, or certain of our
officers and directors may, but are not obligated to, loan us funds as may be
required ("Working Capital Loans"). As of September 30, 2021, there were no
amounts outstanding under any Working Capital Loan.
For the nine months ended September 30, 2021, net cash used in operating
activities was $769,706, which was due to by our net loss of $4,438,654, net
gain on investments in the Trust Account of $1,747, and changes in operating
assets and liabilities of $328,841, offset in part by the change in fair value
of warrants of $3,619,500, a change in fair value of over-allotment option
liability of $225,000, and transaction costs of $155,037.
For the nine months ended September 30, 2021, net cash used in investing
activities was $174,225,000, which was due to the amount of net proceeds from
the Initial Public Offering being deposited to the Trust Account.
For the nine months ended September 30, 2021, net cash provided by financing
activities was $175,758,718, which was comprised of $169,050,000 in proceeds
from the issuance of units in the Initial Public Offering net of underwriter's
discount paid, $16,667 of proceeds from sale of Private Placement Warrants,
$7,175,000 in proceeds from the issuance of warrants in a private placement to
our Sponsor, and proceeds from issuance of Sponsor Note of $188,302, offset in
part by payment of $466,282 for offering costs associated with the Initial
Public Offering, $16,667 payment to related party for cancellation of Founder
Shares, and repayment of the outstanding balance on the promissory note to our
Sponsor of $188,302.
For the period from June 18, 2020 (inception) through September 30, 2020, net
cash provided by financing activity was $25,000, which consisted of $25,000 from
the sale of Founder Shares to the Sponsor, and changes in operating assets and
liabilities of $1,000, which consisted of our net loss of $1,000.
We have incurred and expect to continue to incur significant costs in pursuit of
our acquisition plans. We may have insufficient funds available to operate our
business prior to our initial business combination. Moreover, we may need to
obtain additional financing either to complete our business combination or
because we become obligated to redeem a significant number of public shares upon
completion of our business combination, in which case we may issue additional
securities or incur debt in connection with such business combination.
Off-Balance Sheet Arrangements
We did not have any off-balance sheet arrangements as of September 30, 2021 or
December 31, 2020.
22
Contractual Obligations
Promissory Note - Related Party
On March 1, 2021, the Company issued an unsecured promissory note to the Sponsor
(the "Promissory Note"), pursuant to which the Company could borrow an aggregate
of up to $250,000 to cover expenses related to the Initial Public Offering. The
Promissory Note was non-interest bearing and was payable on the earlier of (i)
Promptly after the date on which the Maker consummates an Initial Public
Offering of its securities or (ii) the completion of the Initial Public
Offering. The outstanding balance under the Promissory Note of $188,302 was
repaid on July 23, 2021. The promissory note is no longer available to the
Company.
Underwriter's Agreement
The Company granted the underwriter a 45-day option to purchase up to 2,250,000
additional Units to cover over-allotments at the Initial Public Offering price,
less the underwriting discounts and commissions. On July 28, 2021, the
Underwriters exercised the over-allotment option in full and purchased an
additional 2,250,000 Units for an aggregate purchase price of $22,500,000.
In connection with the closing of the Initial Public Offering and exercise of
the over-allotment option, the underwriter was paid a cash underwriting fee of
$0.20 per Unit, or $3,450,000 in the aggregate.
Critical Accounting Policies
The preparation of condensed financial statements and related disclosures in
conformity with accounting principles generally accepted in the United States of
America requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities, disclosure of contingent assets and
liabilities at the date of the financial statements, and income and expenses
during the periods reported. Actual results could materially differ from those
estimates. We have identified the following critical accounting policies:
Derivative Warrant Liabilities
The Company accounts for warrants as either equity-classified or
liability-classified instruments based on an assessment of the warrant's
specific terms and applicable authoritative guidance in ASC 480, Distinguishing
Liabilities from Equity ("ASC 480"), and ASC 815, Derivatives and Hedging ("ASC
815"). The assessment considers whether the warrants are freestanding financial
instruments pursuant to ASC 480, meet the definition of a liability pursuant to
ASC 480, and whether the warrants meet all of the requirements for equity
classification under ASC 815, including whether the warrants are indexed to the
Company's own common stock, among other conditions for equity classification.
This assessment, which requires the use of professional judgment, is conducted
at the time of warrant issuance and as of each subsequent quarterly period end
date while the warrants are outstanding.
For issued or modified warrants that meet all of the criteria for equity
classification, the warrants are required to be recorded as a component of
additional paid-in capital at the time of issuance. For issued or modified
warrants that do not meet all the criteria for equity classification, the
warrants are required to be recorded at their initial fair value on the date of
issuance, and each balance sheet date thereafter. Changes in the estimated fair
value of the warrants are recognized as a non-cash gain or loss on the
statements of operations. The fair value of the Private Placement Warrants was
estimated using a Black-Scholes Option Pricing Model (see Note 10). The
subsequent measurement of the Public Warrants as of September 30, 2021 is
classified as Level 1, as such, an observable market quote in an active market
under the ticker CLAQW was used.
The Company evaluates its financial instruments to determine if such instruments
are derivatives or contain features that qualify as embedded derivatives in
accordance with ASC Topic 815, Derivatives and Hedging. For derivative financial
instruments that are accounted for as liabilities, the derivative instrument is
initially recorded at its fair value on the grant date and is then re-valued at
each reporting date, with changes in the fair value reported in the statements
of operations. The classification of derivative instruments, including whether
such instruments should be recorded as liabilities or as equity, is evaluated at
the end of each reporting period. Derivative liabilities are classified in the
balance sheet as current or non-current based on whether or not net-cash
settlement or conversion of the instrument could be required within 12 months of
the balance sheet date.
23
Common stock subject to possible redemption
The Company accounts for its common stock subject to possible redemption in
accordance with the guidance in ASC Topic 480, Distinguishing Liabilities from
Equity. Common stock subject to mandatory redemption (if any) is classified as a
liability instrument and is measured at fair value. Conditionally redeemable
common stock (including Class A common stock that feature redemption rights that
are either within the control of the holder or subject to redemption upon
occurrence of uncertain events not solely within the Company's control) is
classified as temporary equity. At all other times, common stock is classified
as stockholders' equity. The Company's common stock feature certain redemption
rights that are considered to be outside of the Company's control and subject to
the occurrence of uncertain future events. Accordingly, as of September 30,
2021, 17,250,000 common stock subject to possible redemption is presented as
temporary equity, outside of the stockholders' deficit section of the Company's
unaudited condensed balance sheet. Effective with the closing of the Initial
Public Offering, the Company recognized the accretion from the initial book
value to redemption amount, which resulted in charges against additional paid-in
capital (to the extent available) and accumulated deficit.
The Company recognizes changes in redemption value immediately as they occur and
adjusts the carrying value of redeemable common stock to equal the redemption
value at the end of each reporting period. This method would view the end of the
reporting period as if it were also the redemption date for the security.
Increases or decreases in the carrying amount of redeemable common stock are
affected by charges against additional paid in capital and accumulated deficit.
Net Loss Per Share of Common Stock
Net loss per share of common stock is computed by dividing net earnings by the
weighted-average number of shares of common stock outstanding during the period
(for all periods during which these shares were subject to forfeiture, the
calculation of weighted average shares outstanding excludes an aggregate of
562,500 shares of common stock held by the Sponsor that were subject to
forfeiture to the extent that the underwriter's over-allotment was not exercised
in full). The Company has not considered the effect of the Warrants sold in the
Initial Public Offering and private placement to purchase an aggregate of
15,800,000 shares in the calculation of diluted income per share, since the
exercise of the Warrants are contingent upon the occurrence of future events and
the inclusion of such Warrants would be anti-dilutive.
Recent Accounting Standards
In August 2020, the Financial Accounting Standards Board ("FASB") issued
Accounting Standards Update ("ASU") 2020-06, Debt - Debt with Conversion and
Other Options (Subtopic 470-20) and Derivatives and Hedging -Contracts in
Entity's Own Equity (Subtopic 815-40) ("ASU 2020-06") to simplify accounting for
certain financial instruments. ASU 2020-06 eliminates the current models that
require separation of beneficial conversion and cash conversion features from
convertible instruments and simplifies the derivative scope exception guidance
pertaining to equity classification of contracts in an entity's own equity. The
new standard also introduces additional disclosures for convertible debt and
freestanding instruments that are indexed to and settled in an entity's own
equity. ASU 2020-06 amends the diluted earnings per share guidance, including
the requirement to use the if converted method for all convertible instruments.
ASU 2020-06 is effective for the Company on January 1, 2024 and should be
applied on a full or modified retrospective basis, with early adoption permitted
beginning on January 1, 2021. The Company adopted ASU 2020-06 effective January
1, 2021 using the modified retrospective method of transition. The adoption of
ASU 2020-06 did not have a material impact on the financial statements for the
fiscal period ended September 30, 2021.
Management does not believe that any other recently issued, but not yet
effective, accounting standards, if currently adopted, would have a material
effect on the Company's financial statements.
© Edgar Online, source Glimpses